Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diacylglycerol kinase α inhibition cooperates with PD-1-targeted therapies to restore the T cell activation program
Javier Arranz‐Nicolás, Miguel Martin-Salgado, Irene Adán‐Barrientos, et al.
Cancer Immunology Immunotherapy (2021) Vol. 70, Iss. 11, pp. 3277-3289
Open Access | Times Cited: 18

Showing 18 citing articles:

PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
Jinhua Liu, Zichao Chen, Yaqun Li, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 309
The expanding role for small molecules in immuno-oncology
Rienk Offringa, Lisa Kötzner, Bayard R. Huck, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 11, pp. 821-840
Closed Access | Times Cited: 86
Overarching roles of diacylglycerol signaling in cancer development and antitumor immunity
Mariana Cooke, Marcelo G. Kazanietz
Science Signaling (2022) Vol. 15, Iss. 729
Closed Access | Times Cited: 50
Immune Checkpoint Receptors Signaling in T Cells
Gianluca Baldanzi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3529-3529
Open Access | Times Cited: 37
Hyperprogression of cutaneous T cell lymphoma after anti–PD-1 treatment
Yumei Gao, Simeng Hu, Ruoyan Li, et al.
JCI Insight (2023) Vol. 8, Iss. 4
Open Access | Times Cited: 18
Epigenetic regulators combined with tumour immunotherapy: current status and perspectives
Huan Zhang, Yuepeng Pang, Ling Yi, et al.
Clinical Epigenetics (2025) Vol. 17, Iss. 1
Open Access
Strategies to overcome tumor microenvironment immunosuppressive effect on the functioning of CAR-T cells in high-grade glioma
Julia Zarychta, Adrian Kowalczyk, Anna Marszołek, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 3
The Roles of Diacylglycerol Kinase α in Cancer Cell Proliferation and Apoptosis
Fumio Sakane, Fumi Hoshino, Masayuki Ebina, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5190-5190
Open Access | Times Cited: 18
Directing T-Cell Immune Responses for Cancer Vaccination and Immunotherapy
Peter L. Smith, Katarzyna Piadel, Angus Dalgleish
Vaccines (2021) Vol. 9, Iss. 12, pp. 1392-1392
Open Access | Times Cited: 15
Prospective role of PD-1/PD-L1 immune checkpoint inhibitors in GI cancer
Mandana AmeliMojarad, Melika AmeliMojarad, Xiaonan Cui
Pathology - Research and Practice (2023) Vol. 244, pp. 154338-154338
Closed Access | Times Cited: 6
Combination therapy for hepatocellular carcinoma with diacylglycerol kinase alpha inhibition and anti-programmed cell death-1 ligand blockade
Naoki Okada, Ko Sugiyama, Shunsuke Shichi, et al.
Cancer Immunology Immunotherapy (2021) Vol. 71, Iss. 4, pp. 889-903
Open Access | Times Cited: 12
Current studies and future promises of PD-1 signal inhibitors in cervical cancer therapy
Annoor Awadasseid, Yongnan Zhou, Koutian Zhang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 114057-114057
Open Access | Times Cited: 8
Wiskott-Aldrich syndrome protein interacts and inhibits diacylglycerol kinase alpha promoting IL-2 induction
Suresh Velnati, Sara Centonze, Giulia Rossino, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
Diacylglycerol kinases: A look into the future of immunotherapy
Miguel Martin-Salgado, Ane Ochoa-Echeverría, Isabel Mérida
Advances in Biological Regulation (2023) Vol. 91, pp. 100999-100999
Open Access | Times Cited: 3
Diacylglycerol Kinase alpha in X Linked Lymphoproliferative Disease Type 1
Suresh Velnati, Sara Centonze, Federico Girivetto, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5816-5816
Open Access | Times Cited: 6
AI-enabled cancer target prioritization with optimal profiles balancing novelty, confidence and commercial tractability
Xi Long, Barbara Steurer, Chun Wai Wong, et al.
Future Medicine AI (2024) Vol. 2, Iss. 1
Open Access
Steven-Johnson Syndrome/Toxic Epidermal Necrolysis is Associated with PD-1/PD-L1 Inhibitors Usage: A Case Series
Riqu Cao, Tianhong Xu
British Journal of Hospital Medicine (2024), pp. 1-11
Closed Access
Diacylglycerol Kinases and Its Role in Lipid Metabolism and Related Diseases
Yi‐Shi Liu, Zehui Yang, Xiaoman Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 13207-13207
Open Access
Page 1

Scroll to top